TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 173 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,199,043 | -42.3% | 245,978 | -0.9% | 0.00% | -100.0% |
| Q2 2023 | $3,811,523 | -21.8% | 248,146 | +14.5% | 0.00% | 0.0% |
| Q1 2023 | $4,875,135 | +8.7% | 216,769 | +1.7% | 0.00% | 0.0% |
| Q4 2022 | $4,484,080 | -15.0% | 213,223 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $5,276,000 | +14.3% | 214,118 | +12.4% | 0.00% | 0.0% |
| Q2 2022 | $4,615,000 | -18.9% | 190,501 | -13.7% | 0.00% | 0.0% |
| Q1 2022 | $5,689,000 | -17.5% | 220,787 | -0.6% | 0.00% | 0.0% |
| Q4 2021 | $6,894,000 | +27.4% | 222,088 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $5,413,000 | +82.3% | 223,250 | +9.7% | 0.00% | 0.0% |
| Q2 2021 | $2,969,000 | -42.4% | 203,454 | -1.4% | 0.00% | 0.0% |
| Q1 2021 | $5,154,000 | -3.4% | 206,412 | +5.5% | 0.00% | 0.0% |
| Q4 2020 | $5,334,000 | – | 195,689 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |